Tiffany Eul Davis Inglis

SERA

CHIEF MEDICAL OFFICER · SERA PROGNOSTICS, INC. · CIK 0002091798

FILING MIX · LIFETIME80%/20%

BUYS

SELLS

TOTAL VALUE

$728

COMPANIES

ACTIVE SINCE

Oct 2025

HOLDINGS NOW

92,075

AVG SELL PX

$2.01

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Tiffany Eul Davis Inglis. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

SERA · 92,075 shares · as of Jun 11, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2025

2026

FLOW · 4 buys / 1 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
SERA SERA PROGNOSTICS, INC.	SALE Chief Medical Officer	362	$2.01	$728	92,075	Jun 11, 2026	Jun 15, 2026 ↗	View →
SERA SERA PROGNOSTICS, INC.	PURCHASEGRANT Stock grant	27,034	—	—	27,034	Mar 12, 2026	Mar 13, 2026 ↗	View →
SERA SERA PROGNOSTICS, INC.	PURCHASEGRANT Stock grant	17,437	—	—	92,437	Mar 12, 2026	Mar 13, 2026 ↗	View →
SERA SERA PROGNOSTICS, INC.	PURCHASEGRANT Stock grant	107,000	—	—	107,000	Oct 15, 2025	Oct 15, 2025 ↗	View →
SERA SERA PROGNOSTICS, INC.	PURCHASEGRANT Stock grant	75,000	—	—	75,000	Oct 15, 2025	Oct 15, 2025 ↗	View →

Other insiders · SERA

Loading peer insiders…

About this filer

CIK 0002091798

ROLE

Chief Medical Officer

PRIMARY

SERA

COMPANIES

ACTIVE SINCE

Oct 2025

MARKETPEEL · /INSIDER/0002091798DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Tiffany Eul Davis Inglis

The morning brief, before the bell.